Businesses for Sale

Our business is engaged in selling and marketing diabetic and cardiac tablets in our own brand name. - Have tied-up with two third party manufacturers and source the products from two factories. - We have established brands with registered trademarks and our business has a strong presence in South India. - Currently, we distribute to more than 200 stockists from where our products are redistributed to over 10,000 medical shops thereby reaching the consumer. - The revenue has dropped this year as a few medical stores have been shut and we have discontinued the supply of 2 products. - Our products are prescribed by over 4,000 leading doctors for quality, affordability, and availability. - The promoter has an educational background and qualification in MBA, MFM (Finance), and MA, MPhil (Economics). - The business has 2 directors one has an ownership stake of 80% and the other has a 20% stake.

The regional ophthalmology and medical optics market is under-penetrated and rapidly expanding, providing a favorable context for consolidation and accelerated scaling. The company benefits from recurring demand across multiple counties, above-industry operating margins, and an “asset-light” model that enables rapid concept replication with minimal capex. Organic growth of 11–15% annually, achieved without marketing investment, highlights immediate revenue multiplication potential through regional expansion and commercial optimization. Differentiators: • Rare financial performance. ○ Sustained organic growth: CAGR 14% ○ EBITDA to cash conversion: > 90% ○ Solvency and financial risk: Zero debt, 0% financial risk. • Full vertical integration: ophthalmology, medical optics, and in-house laboratory. • Mature brand with 25 years of history and excellent market reputation. • Standardized operational processes, easy to transfer and replicate. • Under-penetrated market with significant regional expansion potential. Scalable operational model. Infrastructure includes state-of-the-art medical equipment and 3 optimized, strategically positioned locations. Stable and high-performing team: 4 ophthalmologists with strong local reputation and 10 specialists (optometrists, technicians, support staff) with an average tenure of 12–18 years. Standardized processes, efficient operational flow. Integrated supply chain from diagnosis to eyewear production, with minimal lead time and reduced costs. Replicable model in nearby cities with minimal investment. Integrated ophthalmology and medical optics platform, with three premium locations and over 20 years of operational history. The business delivers exceptional financial performance, with a premium, supported by an “asset-light” operating model, a stable team, and organic growth of 11–15% annually. The company is completely debt-free, generates predictable cash flow, and offers immediate regional scaling potential. The transaction includes all operational assets, team, and standardized processes.

Online platform providing diagnostic imaging equipment and other medical devices on a rental basis. - Have rented out 6 devices which are owned by the business. - Have purchased these medical devices from 4 vendors. - Seeking funds to buy more medical devices and for marketing purpose. - In addition to imaging rental services, our firm has developed a state-of-the-art technology platform that connects major medical centres, local hospitals and diagnostic providers to a global data-sharing network. - It enables the business to handle and predict the demand for diagnostic equipment rentals at probably the highest terms and conditions on the market. - Since its a new business, we have not yet registered any vendors. - Our assets include a website, customer database, medical devices and office equipment.

We trade in all types of pharmaceutical products such as tablets, syrups, injectables, antacids, anti-viral medicines, medical supplies and devices among many others. - Purchase the products from 3 manufacturers. - Immediate cash flow to the buyer. - Established customer base and actively trading entity. - Selling to government organizations and 3 big hospitals in Cebu City. - Sale would include entire business and physical assets, and if applicable to the concerned parties (new management and employees) the possible hiring of present employees whose loyalty is proven, with knowledge of area and key clients.

• Award-winning medical communications and continuing medical education (CME) organisation based in Mumbai, serving pharmaceutical brand teams and medical affairs departments across India. • Serving 50+ pharmaceutical clients, with the top 10 — predominantly listed Indian pharma majors and multinational subsidiaries — contributing approximately 80% of revenue. • 85% client repeat rate; approximately 60% of revenue recurs through multi-programme annual engagements rather than one-off projects. • Debt-free balance sheet with approximately INR 4.0 crore in cash and quoted investments, and net worth of approximately INR 5.7 crore as at 31 March 2026. • Negligible credit risk: all revenue is contracted against purchase orders from large, predominantly listed pharmaceutical companies. No material bad-debt history. • One of very few Indian firms holding registered media accreditation at more than 50 international medical congresses annually, enabling on-site scientific coverage competitors cannot replicate. • Exclusive India collaboration with the Leicester Diabetes Centre (LDC) and with D&CVD, the educational arm of the European Association for the Study of Diabetes (EASD), for physician clinic certification. • Accredited collaborations across cardiology, heart failure, hypertension, diabetes and gynaecology, and with the Rome Foundation in gastroenterology. • Preferred partner for national consensus documents, delivered in association with 21 national medical societies. • Engaged network of 300+ key opinion leaders, including 100+ international and 50+ Indian faculty across cardiology, endocrinology, gastroenterology, gynaecology and urology. • 6,000 clinic activations completed across India; over 3,000 physician memberships and fellowships facilitated. • Proprietary 'Expert AI' platform — a first-of-its-kind medical AI assistant converting global expert knowledge into an interactive system deployed to physicians via medical representatives. • Recognised at IDF 2025 Bangkok for excellence in medical communications and CME. Winner, IHW Excellence Award for Service Providers, Pharmaceutical Sector (2024) and IHW Silver Award (2020). Three Indian and two international business awards in total. • Lean, profitable structure: 10 full-time employees, 2 working directors, 2 part-time staff, plus a variable freelance scientific writing pool. • Promoters bring over 50 years of combined experience in Indian medico-marketing.

We are a medical tourism and advisory company that helps international clients travel to India for treatment. - Most of our clients are from Middle East and African countries. - We have partnered with over 80 of the top hospital chains pan India. - Revenue is generated through a percentage taken from the hospitals from the cost of client's treatment. - On a monthly basis we normally used to receive around 7-8 patients. However, due to travel restrictions because of the current global scenario, we have not had any patients in the last few months. - Our average monthly revenue before the global situation was INR 4.5 lakh from the beginning of this year. We expect it to reach this level again and grow once the situation stabilizes. - Company has an online presence with a well-designed website and SEO activities. - High-quality ranked keywords are generated to ensure that our website shows up high on google search results. - Website has a domain authority of 21 and an Alexa rank of 1,248,631. - Company's physical assets include office equipment and furniture. - The business is not operational s of now.

A leading medical equipment manufacturing company based in Tehran, specializing in the production of ECG/EKG electrodes and ETT fixators. - The company is focused on serving a diverse client base, including medical equipment manufacturers, hospitals, clinics, and research institutions, both domestically and in export markets in neighboring countries. - There are 150 to 200 clients, out of which 50-60% of them are health centers within Iran. - Production capacity is 30k - 40k ECG electrodes per day. - The primary product, ECG/EKG electrodes, is essential in the medical devices industry and is highly in demand by various healthcare facilities and manufacturers. - The company's secondary product, the ETT fixator, serves a specific niche within the medical devices market and provides an additional revenue stream for the business. - The business has established strong relationships with suppliers, clients, and distributors, indicating a level of stability and reliability in its operations. - Business has certification from the Iran Health Ministry and ISO.